Wegovy (semaglutide) is a once-weekly injection used for chronic weight management
In a double-blind, randomized, clinical trial, a group of sickle cell anemia patients receiving hydroxycarbamide experienced significantly less pain and required fewer blood transfusions than those receiving placebo (Charache 1995)
3 16.7% estimated difference between Wegovy (-16.1%) and placebo (+0.6%) at 68 weeks 3 BMI Reduction Thresholds More patients achieved BMI reductions at multiple thresholds with Wegovy injection at week 68 3 Estimated proportion of patients (%) with BMI reduction at week 68 3 Mean baseline BMI: Wegovy =37.7 kg/m 2
STORAGE Lyophilized 4 C 24 months, 20 C indefinite Reconstituted 28 C, 28 days PEER-REVIEWED EVIDENCE Sikiric P, Sever M, Krezic I, et al
Take 8 ml of the syrup, once daily